• 00Days
  • 00Hrs
  • 00Mins
  • 00Secs

Lumibird Medical

As a world leader in ophthalmology, Lumibird Medical® have accomplished a global presence in over 110 countries either directly or via a distributor network. Enabling a robust route to market through its brands Ellex® and Quantel Medical®, it’s a strength that enables us to equip ophthalmologists with our combined proprietary laser, ultrasound, and dry eye technologies around the world. 

Our global focus continues to remain committed to providing innovative world-class ophthalmic technologies, dedicated to the diagnosis and treatment of leading causes of blindness worldwide: glaucoma, cataracts, AMD, and diabetic retinopathy by offering a combined portfolio of anterior and retinal laser devices to treat a broad range of eye conditions, safely, effectively, accurately, and consistently. 

As a major player in the diagnosis and treatment of glaucoma, Ellex & Quantel Medical have combined their laser technologies to offer a laser therapy solution for every stage of the glaucoma disease – whether that be SLT, Subcyclo or Thermocyco. Ask us today about our Glaucoma Laser Assisted SolutionS (GLASSTM) and how this can help your practice.

For more information please visit the Lumibird Medical® website : https://ophthalmology.lumibirdmedical.com


Abstract submission deadline extended

Important dates
Submission open: NOW!
Submission close: 1 Dec 2023 Monday 15 January 2024
Author notifications: 15 February 2024